BioNTech SE (BNTX) Assets Average (2019 - 2025)
BioNTech SE (BNTX) posted Assets Average of $25.3 billion for Q4 2025, up 2.23% on a QoQ basis from $24.7 billion in Q3 2025, and up 3.84% year-over-year from $24.3 billion in Q4 2024.
BioNTech SE (BNTX) has 7 years of Assets Average data on file, last reported at $25.3 billion in Q4 2025.
- In Q4 2025, Assets Average rose 3.84% year-over-year to $25.3 billion; the TTM figure through Dec 2025 stood at $25.3 billion (up 3.84% YoY), while the FY2025 annual figure was $24.5 billion, changed 0.18% from the prior year.
- Assets Average rose to $25.3 billion in Q4 2025, from $24.7 billion in the prior quarter.
- Across five years, Assets Average topped out at $25.3 billion in Q4 2025 and bottomed at $3.9 billion in Q1 2021.
- A 5-year average of $21.1 billion and a median of $23.6 billion in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2021 — Assets Average jumped 905.48% — and 2025, when it fell 5.26%.
- Year by year, Assets Average stood at $17.4 billion in 2021, then jumped by 33.54% to $23.3 billion in 2022, then grew by 5.0% to $24.5 billion in 2023, then retreated by 0.51% to $24.3 billion in 2024, then grew by 3.84% to $25.3 billion in 2025.
- The last three Assets Average figures came in at $25.3 billion (Q4 2025), $24.7 billion (Q3 2025), and $23.4 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 25.27 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.27 Bn |
| Sep 30, 2025 | 24.72 Bn |
| Jun 30, 2025 | 23.39 Bn |
| Mar 31, 2025 | 23.18 Bn |
| Dec 31, 2024 | 24.34 Bn |
| Sep 30, 2024 | 24.27 Bn |
| Jun 30, 2024 | 24.06 Bn |
| Mar 31, 2024 | 24.47 Bn |
| Dec 31, 2023 | 24.46 Bn |
| Sep 30, 2023 | 24.19 Bn |
| Jun 30, 2023 | 23.95 Bn |
| Mar 31, 2023 | 23.72 Bn |
| Dec 31, 2022 | 23.30 Bn |
| Sep 30, 2022 | 22.71 Bn |
| Jun 30, 2022 | 22.68 Bn |
| Mar 31, 2022 | 20.45 Bn |
| Dec 31, 2021 | 17.45 Bn |
| Sep 30, 2021 | 13.90 Bn |
| Jun 30, 2021 | 8.04 Bn |
| Mar 31, 2021 | 3.92 Bn |
| Dec 31, 2020 | 2.23 Bn |
| Sep 30, 2020 | 1.38 Bn |
| Jun 30, 2020 | 940.26 Mn |
| Mar 31, 2020 | 845.61 Mn |
| Dec 31, 2019 | 852.28 Mn |